A new study sheds light on how molecular subsets within the tumors of kidney cancer patients determine treatment outcomes and underscores the importance of personalized medicine in making therapy decisions.

Tennessee areas where mask requirements were instituted over the summer have substantially lower death rates due to COVID-19 as compared to areas without mask requirements, according to a new analysis by Vanderbilt Department of Health Policy researchers.

Findings from a national study published Nov. 9 in the Journal of the American Medical Association (JAMA) “do not support” the use of hydroxychloroquine for the treatment of adult patients hospitalized with COVID-19, the report concludes.

Hydroxychloroquine (HCQ) did not significantly reduce the incidence of COVID-19 among health care workers who participated in a national study that included Vanderbilt University Medical Center.

Population-wide screening for genetic variants linked to hereditary breast and ovarian cancer may be cost effective in women between the ages of 20 and 35, according to a study published in JAMA Network Open.

How the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) initiative is accelerating development of COVID-19 testing will be the topic of this fall’s second web-based Discovery Lecture.

Vanderbilt University School of Nursing has launched a scholarship program for family nurse practitioner, nurse-midwifery and dual nurse-midwifery/FNP master’s students that aims to increase diversity in primary health care providers, particularly in medically underserved areas.